ITGAM and scleroderma: CD33dim HLA DR+ CD11b+ Myeloid cell was associated with an increased risk of local scleroderma (OR = 1.161, 95% CI = 1.007–1.339, p = 0.040), and CD14 on Monocytic Myeloid-Derived Suppressor Cells was associated with a decreased risk (OR = 0.895, 95% CI = 0.803–0.997, p = 0.044) (Figure 6B).